Although an oral GHSR1a inverse agonist, PF-5190457, reduced alcohol craving in adults with alcohol use disorder with no effect on glucose metabolism, it has not been examined in normal weight or obesity, and effects on appetite and food intake have not been reported [76‐78]. Here, GHSR is linked to obesity disorder.